Activist 13D/13G Filings - F-star Therapeutics Inc. (FSTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-03-17
4:23 pm
Unchanged
13GF-STAR THERAPEUTICS INC
FSTX
Beryl Capital Management LLC0
0%
0
(Unchanged)
View
2023-02-14
4:06 pm
Unchanged
13GF-STAR THERAPEUTICS INC
FSTX
Ridgeback Capital Investments L.P.52,509
0.2%
0
(Unchanged)
View
2023-02-14
4:02 pm
Sale
13GF-STAR THERAPEUTICS INC
FSTX
Ridgeback Capital Investments L.P.52,509
0.2%
-1,781,851decrease
(-97.14%)
View
2022-02-14
6:27 pm
Sale
13GF-STAR THERAPEUTICS INC
FSTX
Rock Springs Capital Management LP751,889
3.65%
-302,343decrease
(-28.68%)
View
2022-02-14
4:45 pm
Sale
13GF-STAR THERAPEUTICS INC
FSTX
Point72 Asset Management L.P.987,111
4.8%
-112,889decrease
(-10.26%)
View
2022-02-14
4:19 pm
Sale
13GF-STAR THERAPEUTICS INC
FSTX
Boxer Capital LLC0
0%
-1,501,428decrease
(Position Closed)
View
2022-02-14
4:15 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
Ridgeback Capital Investments L.P.1,834,360
8.9%
1,340,000increase
(+271.06%)
View
2022-02-11
5:42 pm
Unchanged
13GF-STAR THERAPEUTICS INC
FSTX
Atlas Venture Opportunity Fund I L.P.599,524
2.9%
0
(Unchanged)
View
2022-02-10
4:50 pm
Sale
13GF-STAR THERAPEUTICS INC
FSTX
GSK plc
GSK
802,627
3.9%
-1,295decrease
(-0.16%)
View
2022-02-08
5:00 pm
Sale
13GF-STAR THERAPEUTICS INC
FSTX
Merck KGaA75,140
0.1%
-418,570decrease
(-84.78%)
View
2021-05-26
4:31 pm
Unchanged
13DF-STAR THERAPEUTICS INC
FSTX
Cooperatieve AESCAP Venture I U.A.615,643
3.1%
0
(Unchanged)
View
2021-05-18
4:32 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
Point72 Asset Management L.P.1,100,000
5.7%
1,100,000increase
(New Position)
View
2021-05-17
4:17 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
Rock Springs Capital Management LP1,054,232
5.73%
1,054,232increase
(New Position)
View
2021-05-17
4:15 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
Boxer Capital LLC1,501,428
8.2%
1,501,428increase
(New Position)
View
2021-04-09
4:54 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
Ridgeback Capital Investments L.P.494,360
5.4%
86,793increase
(+21.30%)
View
2021-02-16
4:20 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
Ridgeback Capital Investments L.P.407,567
4.5%
407,567increase
(New Position)
View
2021-02-12
8:17 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
BIOTECHNOLOGY VALUE FUND L P25,844
1%
25,844increase
(New Position)
View
2021-02-03
5:20 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
Atlas Venture Fund VII L P574,996
6.3%
574,996increase
(New Position)
View
2021-02-03
5:14 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
Atlas Venture Opportunity Fund I L.P.599,524
6.6%
599,524increase
(New Position)
View
2021-02-01
4:32 pm
Purchase
13GF-STAR THERAPEUTICS INC
FSTX
Merck KGaA493,710
5.4%
493,710increase
(New Position)
View
Goto 0, 1, Next